Lv5
1028 积分 2023-04-17 加入
Safety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes
10天前
已完结
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes
10天前
已完结
Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation
10天前
已完结
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)
10天前
已完结
Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes
10天前
已完结
基于EVIDEM医疗机构多准则循证决策框架评估伏诺拉生与艾普拉唑
26天前
已完结
基于EVIDEM理念的医疗机构药品遴选多准则循证决策框架探究
30天前
已完结
Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians
1个月前
已完结
皖公网安备34019202002308
